Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) management will conduct a conference call for 11th August 2020 at 4:30 PM Eastern Time to discuss financial results and companys performance for 2Q20.
The conference call will also be available live on the website www.auriniapharma.com
Earnings Expectation
Aurinia Pharmaceuticals Inc is set to announce second quarter earning results on Tuesday 11th August 2020, after market close.
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutic drugs for the treatment of various diseases in the United States and China. The company is involved in developing voclosporin, an investigational drug for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis. Aurinia Pharmaceuticals Inc.
